1.
Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis. Dermatol Pract Concept [Internet]. 2023 Oct. 31 [cited 2024 Dec. 6];13(4):e2023215. Available from: https://dpcj.org/index.php/dpc/article/view/3114